LB-46 in angina pectoris. A critique of anti-anginal drug assessment.
dc.contributor.author | Ganeshan, K P | en_US |
dc.contributor.author | Xavier, K B | en_US |
dc.date.accessioned | 1972-06-01 | en_US |
dc.date.accessioned | 2009-05-27T04:18:38Z | |
dc.date.available | 1972-06-01 | en_US |
dc.date.available | 2009-05-27T04:18:38Z | |
dc.date.issued | 1972-06-01 | en_US |
dc.identifier.citation | Ganeshan KP, Xavier KB. LB-46 in angina pectoris. A critique of anti-anginal drug assessment. Indian Heart Journal. 1972 Jun; 24(): Suppl 1:197-20 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/3218 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://indianheartjournal.com | en_US |
dc.subject.mesh | Adrenergic beta-Antagonists --therapeutic use | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Angina Pectoris --drug therapy | en_US |
dc.subject.mesh | Clinical Trials as Topic | en_US |
dc.subject.mesh | Electrocardiography | en_US |
dc.subject.mesh | Evaluation Studies as Topic | en_US |
dc.subject.mesh | Heart Rate --drug effects | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Pindolol --therapeutic use | en_US |
dc.subject.mesh | Placebos | en_US |
dc.subject.mesh | Propranolol --administration & dosage | en_US |
dc.title | LB-46 in angina pectoris. A critique of anti-anginal drug assessment. | en_US |
dc.type | Clinical Trial | en_US |
dc.type | Comparative Study | en_US |
dc.type | Controlled Clinical Trial | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1